R J North
About
R J North is a scholar working on Immunology, Infectious Diseases and Oncology.
According to data from OpenAlex, R J North has authored 161 papers receiving a total of 13.0k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Immunology, 41 papers in Infectious Diseases and 31 papers in Oncology. Recurrent topics in R J North's work include Immune Response and Inflammation (37 papers), Tuberculosis Research and Epidemiology (36 papers) and Immunotherapy and Immune Responses (30 papers). R J North is often cited by papers focused on Immune Response and Inflammation (37 papers), Tuberculosis Research and Epidemiology (36 papers) and Immunotherapy and Immune Responses (30 papers). R J North collaborates with scholars based in United States, Australia and Canada. R J North's co-authors include J. Wayne Conlan, Yu‐Jin Jung, Pamela Dunn, Lynn Ryan, Ronald LaCourse, Michel Awwad, M J Berendt, Carl Nathan, John S. Mudgett and John D. MacMicking and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Experimental Medicine.
In The Last Decade
R J North
157 papers receiving 12.1k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| R J North United States | 61 | 6.8k | 3.7k | 3.1k | 2.9k | 2.5k | 161 | 13.0k | ||
| Paolo Puccetti Italy | 78 | 10.8k 1.6× | 4.1k 1.1× | 3.4k 1.1× | 4.7k 1.6× | 2.4k 1.0× | 255 | 21.4k | ||
| Martin Röllinghoff Germany | 65 | 8.1k 1.2× | 2.0k 0.5× | 3.8k 1.2× | 2.4k 0.8× | 1.4k 0.6× | 249 | 15.0k | ||
| Yasunobu Yoshikai Japan | 68 | 12.4k 1.8× | 1.4k 0.4× | 2.1k 0.7× | 4.0k 1.4× | 2.5k 1.0× | 389 | 18.6k | ||
| Martin F. Kagnoff United States | 69 | 8.1k 1.2× | 2.6k 0.7× | 3.1k 1.0× | 4.6k 1.6× | 2.1k 0.9× | 208 | 19.0k | ||
| Makoto Matsumoto Japan | 44 | 10.1k 1.5× | 2.1k 0.6× | 3.0k 1.0× | 5.7k 2.0× | 2.1k 0.9× | 173 | 17.9k | ||
| Paul J. Godowski United States | 51 | 9.8k 1.4× | 1.7k 0.5× | 3.0k 1.0× | 6.6k 2.3× | 1.8k 0.7× | 64 | 18.6k | ||
| Sucharit Bhakdi Germany | 65 | 4.6k 0.7× | 2.9k 0.8× | 1.7k 0.5× | 5.6k 2.0× | 713 0.3× | 272 | 14.5k | ||
| Marina A. Freudenberg Germany | 61 | 12.9k 1.9× | 1.5k 0.4× | 3.7k 1.2× | 5.1k 1.8× | 1.8k 0.7× | 170 | 20.9k | ||
| Maurice K. Gately United States | 58 | 11.9k 1.8× | 1.2k 0.3× | 2.5k 0.8× | 2.3k 0.8× | 3.4k 1.4× | 114 | 16.3k | ||
| Ichiro Azuma Japan | 51 | 3.0k 0.4× | 1.1k 0.3× | 1.4k 0.4× | 3.4k 1.2× | 1.3k 0.5× | 352 | 9.5k |
Countries citing papers authored by R J North
Since
Specialization
Citations
This map shows the geographic impact of R J North's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R J North with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R J North more than expected).
Fields of papers citing papers by R J North
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by R J North. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R J North. The network helps show where R J North may publish in the future.
Co-authorship network of co-authors of R J North
This figure shows the co-authorship network connecting the top 25 collaborators of R J North. A scholar is included among the top collaborators of R J North based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R J North. R J North is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Shi, Lanbo, Charles D. Sohaskey, Pratik Datta, et al.. (2010). Carbon flux rerouting during Mycobacterium tuberculosis growth arrest. Molecular Microbiology. 78(5). 1199–1215.
2.
Marquis, Jean-François, Ronald LaCourse, Lynn Ryan, R J North, & Philippe Gros. (2009). Disseminated and Rapidly Fatal Tuberculosis in Mice Bearing a Defective Allele at IFN Regulatory Factor 8. The Journal of Immunology. 182(5). 3008–3015.
3.
Marquis, Jean-François, Ronald LaCourse, Lynn Ryan, R J North, & Piet Gros. (2009). Genetic and Functional Characterization of the Mouse Trl3 Locus in Defense against Tuberculosis. The Journal of Immunology. 182(6). 3757–3767.
4.
Rogerson, Brian J., et al.. (2006). Expression levels of Mycobacterium tuberculosis antigen‐encoding genes versus production levels of antigen‐specific T cells during stationary level lung infection in mice. Immunology. 118(2). 195–201.
5.
Shi, Lanbo, Yu‐Jin Jung, Sanjay Tyagi, Maria Laura Gennaro, & R J North. (2002). Expression of Th1-mediated immunity in mouse lungs induces a Mycobacterium tuberculosis transcription pattern characteristic of nonreplicating persistence. Proceedings of the National Academy of Sciences. 100(1). 241–246.
6.
Conlan, J. Wayne & R J North. (1994). Neutrophils are essential for early anti-Listeria defense in the liver, but not in the spleen or peritoneal cavity, as revealed by a granulocyte-depleting monoclonal antibody.. The Journal of Experimental Medicine. 179(1). 259–268.
7.
Rakhmilevich, Alexander L., et al.. (1993). EVIDENCE INCONSISTENT WITH A ROLE FOR TUMOR NECROSIS FACTOR IN TUMOR ALLOGRAFT REJECTION. Transplantation. 55(1). 182–185.
8.
Dunn, Pamela & R J North. (1991). The Importance of Route of Infection in Determining the Extent of Exacerbation of Listeriosis by Anti-Interferon-γ Monoclonal Antibody. Journal of Interferon Research. 11(5). 291–295.
9.
North, R J, Pamela Dunn, & Edward A. Havell. (1991). A Role for Tumor Necrosis Factor in Poly(I:C)-Induced Hemorrhagic Necrosis and T-Cell-Dependent Regression of a Murine Sarcoma. Journal of Interferon Research. 11(6). 333–340.
10.
Hill, J O, Michel Awwad, & R J North. (1989). Elimination of CD4+ suppressor T cells from susceptible BALB/c mice releases CD8+ T lymphocytes to mediate protective immunity against Leishmania.. The Journal of Experimental Medicine. 169(5). 1819–1827.
11.
North, R J & Edward A. Havell. (1989). Glucocorticoid-mediated inhibition of endotoxin-induced intratumor tumor necrosis factor production and tumor hemorrhagic necrosis and regression.. The Journal of Experimental Medicine. 170(3). 703–710.
12.
North, R J, et al.. (1988). Interleukin 1-induced, T cell-mediated regression of immunogenic murine tumors. Requirement for an adequate level of already acquired host concomitant immunity.. The Journal of Experimental Medicine. 168(6). 2031–2043.
13.
North, R J & Edward A. Havell. (1988). The antitumor function of tumor necrosis factor (TNF) II. Analysis of the role of endogenous TNF in endotoxin-induced hemorrhagic necrosis and regression of an established sarcoma.. The Journal of Experimental Medicine. 167(3). 1086–1099.
14.
North, R J. (1986). Radiation-induced, immunologically mediated regression of an established tumor as an example of successful therapeutic immunomanipulation. Preferential elimination of suppressor T cells allows sustained production of effector T cells.. The Journal of Experimental Medicine. 164(5). 1652–1666.
15.
North, R J, et al.. (1982). Non-H-2 restriction of expression of passively transferred delayed sensitivity.. The Journal of Experimental Medicine. 155(5). 1334–1343.
16.
Berendt, M J & R J North. (1980). T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor.. The Journal of Experimental Medicine. 151(1). 69–80.
17.
North, R J, et al.. (1977). T-cell-mediated concomitant immunity to syngeneic tumors. I. Activated macrophages as the expressors of nonspecific immunity to unrelated tumors and bacterial parasites.. The Journal of Experimental Medicine. 145(2). 275–292.
18.
North, R J. (1973). CELLULAR MEDIATORS OF ANTI-LISTERIA IMMUNITY AS AN ENLARGED POPULATION OF SHORT-LIVED, REPLICATING T CELLS. The Journal of Experimental Medicine. 138(2). 342–355.
19.
North, R J. (1970). SUPPRESSION OF CELL-MEDIATED IMMUNITY TO INFECTION BY AN ANTIMITOTIC DRUG. The Journal of Experimental Medicine. 132(3). 535–545.
20.
North, R J. (1970). THE RELATIVE IMPORTANCE OF BLOOD MONOCYTES AND FIXED MACROPHAGES TO THE EXPRESSION OF CELL-MEDIATED IMMUNITY TO INFECTION. The Journal of Experimental Medicine. 132(3). 521–534.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Paolo Puccetti Breakdown of academic impact, for papers by Martin Röllinghoff Breakdown of academic impact, for papers by Yasunobu Yoshikai Breakdown of academic impact, for papers by Martin F. Kagnoff Breakdown of academic impact, for papers by Makoto Matsumoto Breakdown of academic impact, for papers by Paul J. Godowski Breakdown of academic impact, for papers by Sucharit Bhakdi Breakdown of academic impact, for papers by Marina A. Freudenberg Breakdown of academic impact, for papers by Maurice K. Gately Breakdown of academic impact, for papers by Ichiro Azuma